Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
183.33
-4.24 (-2.26%)
At close: Mar 31, 2026, 4:00 PM EDT
183.00
-0.33 (-0.18%)
After-hours: Mar 31, 2026, 7:51 PM EDT
Biogen Analyst Ratings
Total Analysts
28
Consensus Rating
Buy
Price Target
$195.00
Upside
+6.37%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HSBC | HSBC | Sell Maintains $143 → $150 | Sell | Maintains | $143 → $150 | -18.18% | Mar 17, 2026 |
| Barclays | Barclays | Hold Initiates $185 | Hold | Initiates | $185 | +0.91% | Feb 20, 2026 |
| Wedbush | Wedbush | Hold Maintains $178 → $187 | Hold | Maintains | $178 → $187 | +2.00% | Feb 10, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $220 → $230 | Strong Buy | Maintains | $220 → $230 | +25.46% | Feb 9, 2026 |
| BMO Capital | BMO Capital | Hold Maintains $165 → $196 | Hold | Maintains | $165 → $196 | +6.91% | Feb 9, 2026 |
| Piper Sandler | Piper Sandler | Hold Maintains $157 → $177 | Hold | Maintains | $157 → $177 | -3.45% | Feb 9, 2026 |
| TD Cowen | TD Cowen | Strong Buy Maintains $175 → $215 | Strong Buy | Maintains | $175 → $215 | +17.27% | Feb 9, 2026 |
| Citigroup | Citigroup | Hold Maintains $185 → $215 | Hold | Maintains | $185 → $215 | +17.27% | Feb 9, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $217 → $233 | Buy | Maintains | $217 → $233 | +27.09% | Feb 9, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $185 → $246 | Strong Buy | Maintains | $185 → $246 | +34.18% | Feb 9, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $190 → $200 | Hold | Maintains | $190 → $200 | +9.09% | Feb 9, 2026 |
| Truist Securities | Truist Securities | Hold Maintains $190 → $193 | Hold | Maintains | $190 → $193 | +5.27% | Feb 9, 2026 |
| Wedbush | Wedbush | Hold Maintains $178 → $187 | Hold | Maintains | $178 → $187 | +2.00% | Feb 9, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $194 → $228 | Strong Buy | Maintains | $194 → $228 | +24.37% | Feb 9, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $205 → $225 | Buy | Maintains | $205 → $225 | +22.73% | Jan 30, 2026 |
| Citigroup | Citigroup | Hold Maintains $180 → $185 | Hold | Maintains | $180 → $185 | +0.91% | Jan 27, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.